Skip to main content
. 2018 Feb 8;39(8):1393–1404. doi: 10.1038/aps.2017.144

Figure 3.

Figure 3

(A) Effects of various chemical inhibitors of CYP enzymes on CTS metabolism in HLM (KTC: ketoconazole, QND: quinidine, FUR: Furafylline, MOS: methoxsalen, QUE: quercetin, SUL: sulfaphenazole, TIC: ticlopidine). (B) The metabolism of cryptotanshinone by CYP recombinant enzymes. * P<0.05 vs control group.